Wu Haixia, Anti-Cancer Association: Disintegrate Tumors with Ultrasound! New technology can inhibit cancer metastasis and recurrence.

　　Recently, the University of Michigan in the United States brought a non-invasive acoustic wave anti-cancer technology, which can continuously decompose liver tumors in rats. This process can kill some cancer cells and activate the immune system function to prevent cancer cells from further metastasis and spread. This may solve the problem of cancer recurrence and improve the prognosis of patients.

　　This kind of ultrasonic pulse will produce some tiny bubbles in the target tissue, and these bubbles will expand and rupture rapidly in a short time, which will exert great mechanical pressure on the tissue in the process, thus killing cells. If you aim directly at the tumor area, the cancer tissue will quickly fall apart, some will die, and some will become fragments.

　　The research team tested the technology in rats with liver tumors, and found that the research can regulate the damage degree of ultrasound technology, and the tumor can be treated significantly only by destroying 50%-70% of the tumor volume. The part of the tumor that has not been destroyed will be significantly reduced due to the impact, and the immune system of rats will be more sensitive to the residual tumor and can directly remove the remaining cancer cells.

　　After ultrasonic treatment, 80% of rats did not have recurrence or cancer metastasis. "Even if it doesn’t work for the whole tumor, we can still make the tumor subside and reduce the risk of cancer metastasis in the future." Dr. Zhen Xu, the correspondent of the study, said. In addition, this treatment can further activate the immune system of rats, which is helpful to the regression and prevention of tumor spread.

　　After using the new technology, the tumor volume decreases rapidly, and basically does not recur (source: reference [Tejas Wiworlikar et al, Impact of Histotripsy on Development of Intrahepatic Metastases in a Rodent Liver Tumour Model, Cancers (2022). DOI: 10.3390/Cancers 14071612].

　　There is no need for surgery in the whole treatment process, and there are almost no side effects. This means that ultrasound therapy can gain huge benefits at a very low price. According to the research, this type of technology is now being tested in human liver cancer trials in the United States and Europe. The research team also hopes to see more preclinical and clinical trial results in the future and accelerate the application of this technology in patients.

　　Research progress and clinical application in China

　　Since 2000, Jiangsu Hanmei Technology Co., Ltd. and Taizhou Tumor Ultrasound Technology Research Team have carried out applied research on this theory in conjunction with Harvard Medical School, Houston Medical Center and Institute of Medical Applied Technology of Southeast University. After ten years, they have achieved breakthrough results and invented a brand-new non-invasive ultrasound treatment method for tumors-tumor ultrasound tissue precise fragmentation treatment, which has brought a brand-new treatment model and new hope for life rehabilitation for tumor patients.

　　Wu Haixia, Anti-cancer Association: Sticking to the Road of Anti-cancer for More than 30 Years

　　Beijing Nanjiao Cancer Hospital (International Department, 2nd Floor, Cooperation South Campus, Peking University Cancer Hospital) Tumor Expert of Integrated Chinese and Western Medicine.

　　Director Wu Haixia was an authorized expert of "Patent Technology of Anti-tumor Traditional Chinese Medicine".

　　Wu Haixia: member of Beijing Anti-Cancer Association, oncologist of integrated traditional Chinese and western medicine in the international department on the second floor of the South Campus of Peking University Cancer Hospital, and director of oncology department of Beijing Fengtai Guangji Integrated Traditional Chinese and Western Medicine Hospital.

　　The national patent "An Oral Liquid for Malignant Tumors and its Preparation Method" approved by Beijing has been proved by clinical trials and research that this patented Chinese medicine plays an important role in the treatment of tumors, the improvement of bone marrow suppression after chemotherapy, the reduction of toxic side effects and the enhancement of patients’ immunity, and has authorized Director Wu Haixia of Beijing Fengtai Guangji Hospital of Integrated Traditional Chinese and Western Medicine to apply it in the clinical treatment of traditional Chinese medicine tumors. Our hospital has been engaged in the research and diagnosis of anti-tumor traditional Chinese medicine for many years, and has accumulated rich clinical experience, which has won unanimous praise from the society and the industry.

　　[Disclaimer: This content is reproduced on the Internet and does not belong to this website. It is only used for health science popularization, not for any commercial advertising purposes, and it does not provide advice on diagnosis and treatment, nor can it replace the examination and treatment in hospitals. If you have related diseases, please go to a regular medical institution in time and follow the doctor’s advice. If there is any infringement of the pictures and other contents in the text, please contact the editor to delete them. 】

　　Xinhua News Agency, Beijing, November 4 (Reporter Jiang Lin) The Ministry of Human Resources and Social Security, the Ministry of Finance, State Taxation Administration of The People’s Republic of China, China Banking and Insurance Regulatory Commission and the China Securities Regulatory Commission jointly issued the Measures for the Implementation of Individual Pensions on November 4, which made specific provisions on the participation process, fund account management, organization and product management, information disclosure, supervision and management of individual pensions.

　　According to Jia Jiang, deputy director of the Pension Insurance Department of the Ministry of Human Resources and Social Security, personal pension is a supplementary pension insurance system supported by government policies, voluntary participation by individuals and market-oriented operation. Workers who participate in the basic old-age insurance for urban workers or the basic old-age insurance for urban and rural residents in China can participate.

　　The method is clear. Participants who participate in personal pensions should open personal pension accounts on the information platform through the national unified online service portals such as the national social insurance public service platform, the national human resources and social security government service platform, the electronic social security card, the handheld 12333App and other commercial bank channels. After that, choose a commercial bank that meets the requirements to open or designate my only personal pension fund account.

　　"These two accounts are unique and correspond to each other. These two accounts can be opened at one time through commercial bank channels. " Jia Jiang said that the funds in the account can be used to purchase qualified wealth management products, savings deposits, commercial endowment insurance and Public Offering of Fund.

　　The method stipulates that the maximum amount of personal pension paid by participants each year is 12,000 yuan. Personal pension fund accounts are closed, and participants can receive personal pensions when they reach the age of receiving basic pensions, or completely lose their ability to work, go abroad (settle down), and meet other circumstances stipulated by the state.

　　In order to safeguard the interests of participants, the measures emphasize that sales organizations should make risk warnings based on the principle of "sales appropriateness" and should not actively introduce personal pension products beyond their risk tolerance to participants.